அமெரிக்கன் மருந்து சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமெரிக்கன் மருந்து சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமெரிக்கன் மருந்து சங்கம் Today - Breaking & Trending Today

Qatari study reveals effectiveness of vaccination, prior infection in preventing Covid-19


 13 Jun 2021 - 18:33
File Photo. Reuters
QNA
Doha: A study carried out by investigators and collaborators from Qatar s healthcare system and research institutes supports previous research showing that full vaccination and prior infection are both highly effective at preventing Covid-19 and rationalizes resumption of international travel in the era of Covid-19.
The research paper, published in the prestigious Journal of the American Medical Association, involved a team of researchers from the Ministry of Public Health, Hamad Medical Corporation, Weill Cornell Medicine-Qatar, and Qatar University.
Dr Roberto Bertollini, Senior Advisor to the Minister of Public Health and Deputy National Lead for Health in All Policies, and lead study investigator, explained the study aims. Using PCR test data for residents arriving on international flights to Doha s Hamad International Airport, we assessed whether full vaccination with either Pfizer-BioNTech or Moderna vaccine ....

South Africa , Ad Daw Ah , United States , United Kingdom , Roberto Bertollini , Abdullatif Al Khal , Al Khal , Hamad Medical Corporation , Deputy National Lead For Health , Journal Of The American Medical Association , Public Health , Doha Hamad International Airport , Qatar Foundation , Ministry Of Public Health , Hamad International Airport , Airline Passengers , National Health Strategic Group , Journal Of American Medicine Association , Qatar University , American Medical Association , Weill Cornell Medicine Qatar , Senior Advisor , Deputy National Lead , Wall Policies , New England Journal , Professor Laith Abu Raddad ,